Instem Reports a Strong H1 2022

Proactive interview with Phil Reason,
Instem CEO

Investor Meet Company: Results and Company Update
September 2022

Presentation now available to watch on-demand

Watch Now

A global provider of leading software solutions
and services to the life sciences community.

The future transformed for the benefit of everyone.
Intelligent solutions empowering collaboration and life-enhancing science.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.

Latest News

13 March 2023 - No Exposure to Silicon Valley Bank

Read More

31 January 2023 - Trading Update

Read More

09 January 2023 - Appointment of Independent Non-Executive Director

Read More

Annual Report 2021

Impressive growth in FY22

Annual Report 2021

Our achievements and performance in 2021 have been exceptional and we have accomplished a fundamental strategic shift in scale and reach having completed three important acquisitions.

Impressive growth in FY22

Research Note by Gareth Evans of Progressive Equity Research